Accumulation

Accumulation is the buildup of a substance or its metabolites in the body when doses arrive faster than elimination can clear them. Each dose adds to what remains of the last, and concentrations can settle at a level substantially higher than any single occasion would produce.

The problem this creates for harm reduction is one of calibration. A person whose reference point is a single exposure — one night's effects, one session — has no reliable basis for predicting what a multi-day pattern at the same apparent dose will produce.

How it is done

Accumulation follows from the relationship between dosing frequency and a drug's half-life: the time the body takes to clear half of what is present. When each dose arrives before the previous one has fully cleared, the residual adds to the incoming dose, and the trough concentration rises with each cycle.

After several repetitions, concentrations approach a steady state — a plateau determined by the dose and the half-life — where the amount eliminated between doses matches the amount added. That plateau can sit substantially higher than the single-dose peak.

Active metabolites complicate this further. Some substances are broken down into compounds that remain pharmacologically active and carry even longer half-lives than the parent drug. The metabolite can accumulate faster and more extensively, its contribution to effects building while the original substance appears to be clearing.

When it matters

Accumulation is most consequential at the start of a new pattern — when concentrations are still climbing toward steady state — and when a dosing schedule changes after a period of stability.

Certain long-acting substances are associated with sedation that deepens days after a regimen begins, after early doses appeared tolerable. This delay between first exposure and the peak of the accumulation curve can be missed: the absence of difficulty on earlier days gives no warning that later concentrations will be substantially higher. In clinical and non-clinical settings alike, this timing has been responsible for serious harm.

What it cannot tell you

Accumulation rarely announces itself. Concentrations can rise over days with no perceptible change in effect — particularly when tolerance develops in parallel, blunting the signal. A pattern that has felt consistent may not be.

The specific failure mode is trusting sameness: because the last several doses produced familiar effects, the assumption follows that the next will too. At steady state, that assumption holds. During the build-up phase, it does not. The margin before effects intensify, or a side-effect threshold is crossed, narrows invisibly.

Knowing that a substance has a long half-life does not establish how high concentrations have actually risen, or whether steady state has been reached. That requires measurement.